Figure 7

Effects of a subcutaneous administration of exendin-4 (100 nmol/kg, s.c.) on gastric myoelectric activity. (A) Running spectrum analysis of a control ferret that had received saline s.c.; (B) running spectrum analysis of a ferret that received exendin-4 but without emesis; (C) running spectrum analysis of a ferret that received exendin-4 inducing four episodes of emesis. a. baseline, b. saline or exendin-4 injection; c. during episodes of emesis. Each line represents 10 min of data.